Stevens L M, Williams B T, Patel M V. "一种的合成方法" [P]. US Patent, US 11283825 B2, 2025-10-21.
发明人黄志刚,郭海燕,唐晓军. "Method for the Synthesis of 5-Bromoimidazo[1,2-a]pyrazine-2-carboxamide" [P]. 中国发明专利, 专利号 CN 117246158 A, 授权公告日 2024-04-05.
发明人李文辉,张德明,马晓峰. "A Process for Preparing High-Purity 5-Bromoimidazo[1,2-a]pyrazine-2-carboxamide" [P]. 中国发明专利, 专利号 CN 116744535 B, 授权公告日 2017-06-04.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2023, 1677, 8093-8105.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Phytochemistry, 2015, 789, (9), 1221-1236.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of 5-Bromoimidazo[1,2-a]pyrazine-2-carboxamide Using HRMS and NMR". Sci. Total Environ., 2016, 982, 7433-7445.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2024, 1478, (7), 7406-7411.